Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Mohamed Abdelbaky | Pharmaceutical Science | Best Researcher Award

Professor-Biochemistry from Avalon Medical School, Curaçao

Dr. Mohamed Fakhry Mohamed Abdelbaky is a distinguished professor of biochemistry with a robust academic and research background spanning over two decades. He earned his PhD in Biochemistry from Glasgow Caledonian University, UK, in 2011, following his MSc and MB.B.Ch from Minya University, Egypt. Dr. Abdelbaky has held significant academic positions across various international institutions, including Avalon University School of Medicine in Curaçao, Texila American University in Guyana, and Al Maarefa University in Saudi Arabia. His roles have encompassed curriculum development, teaching, student evaluation, and administrative leadership. His research interests are diverse, focusing on molecular biology, cancer research, and pharmacological studies, with numerous publications in reputable journals. Dr. Abdelbaky’s commitment to education and research excellence is evident through his active participation in academic committees, mentorship, and continuous professional development. His contributions have significantly advanced the field of biochemistry, making him a valuable asset to the scientific community.

Professional Profile

Education

Dr. Abdelbaky’s educational journey reflects a strong foundation in medical and biochemical sciences. He obtained his Bachelor of Medicine and Surgery (MB.B.Ch) from the Faculty of Medicine, Minya University, Egypt, in 2000. Pursuing his passion for biochemistry, he completed his Master of Science (MSc) in Biochemistry at the same institution in 2006, where his thesis focused on the effects of plasma homocysteine on VEGF levels in platelets and neutrophils. To further enhance his expertise, he pursued a PhD in Biochemistry and Molecular Biology at Glasgow Caledonian University, UK, completing it in 2011. His doctoral research investigated the biological effects of the proto-oncoprotein EVI1 in normal and transformed fibroblasts. This comprehensive educational background has equipped Dr. Abdelbaky with the knowledge and skills necessary to excel in both academic and research settings, contributing significantly to the field of biochemistry.

Professional Experience

Dr. Abdelbaky’s professional career is marked by a series of progressive academic appointments and responsibilities. He began as a Teaching Assistant at Minya University, Egypt, where he was involved in designing and supervising laboratory experiments for medical students. His dedication led to his promotion to Assistant Lecturer and subsequently to Lecturer, where he continued to contribute to teaching and research activities. He expanded his international experience by serving as a Postgraduate Demonstrator at Glasgow Caledonian University, UK, where he supervised laboratory sessions and research projects for science students. Dr. Abdelbaky furthered his academic career as an Assistant Professor at Al Maarefa University in Saudi Arabia, teaching medical biochemistry and genetics to students of various health science programs. He later joined Texila American University in Guyana as an Associate Professor, where he was responsible for curriculum design and delivery of biochemistry and medical genetics courses. Currently, he holds the position of Professor at Avalon University School of Medicine in Curaçao, where he continues to contribute to curriculum development, teaching, and student mentorship. Throughout his career, Dr. Abdelbaky has demonstrated a commitment to academic excellence and leadership in biochemistry education.

Research Interests

Dr. Abdelbaky’s research interests are centered around molecular biology, cancer research, and pharmacological studies. He has a particular focus on understanding the molecular mechanisms underlying various diseases, including cancer and metabolic disorders. His research explores the roles of specific genes and proteins in disease progression and treatment responses. Dr. Abdelbaky is also interested in the development and evaluation of pharmacological agents for disease prevention and therapy. His work often involves investigating the effects of natural compounds and pharmaceuticals on cellular and molecular pathways. Through his research, Dr. Abdelbaky aims to contribute to the development of effective diagnostic and therapeutic strategies for complex diseases, ultimately improving patient outcomes.

Research Skills

Dr. Abdelbaky possesses a comprehensive set of research skills that enable him to conduct advanced studies in biochemistry and molecular biology. He is proficient in tissue culture techniques, allowing for the cultivation and maintenance of various cell lines for experimental purposes. His expertise includes the isolation of DNA, RNA, and proteins, essential for analyzing gene and protein expression. Dr. Abdelbaky is skilled in polymerase chain reaction (PCR) and reverse transcription PCR (RT-PCR), techniques crucial for amplifying and studying specific DNA and RNA sequences. He is experienced in gene knockdown methods, which are used to study gene function by reducing gene expression. Additionally, he is adept at performing agarose and polyacrylamide gel electrophoresis (PAGE) for the separation and analysis of nucleic acids and proteins. These technical skills are fundamental to his research endeavors, enabling him to investigate complex biological processes and contribute valuable insights to the field of biochemistry.

Awards and Honors

Throughout his career, Dr. Abdelbaky has received recognition for his contributions to biochemistry and medical education. He is a member of several prestigious professional societies, including the Academy of Medical Educators (AoME) in the UK, the Egyptian Medical Syndicate, and the Egyptian Society of Medical Biochemistry. His active participation in these organizations reflects his commitment to professional development and collaboration within the scientific community. Dr. Abdelbaky has also contributed to the peer-review process for scientific journals, demonstrating his expertise and dedication to maintaining high standards in research publication. His involvement in continuous medical education (CME) programs and attendance at international conferences further highlight his pursuit of knowledge and excellence in his field. These accolades and affiliations underscore Dr. Abdelbaky’s standing as a respected figure in biochemistry and medical education.

Conclusion

Dr. Mohamed Fakhry Mohamed Abdelbaky’s extensive academic background, international teaching experience, and robust research portfolio position him as a leading figure in the field of biochemistry. His dedication to education is evident through his curriculum development efforts, mentorship, and active participation in academic committees. His research contributions have advanced the understanding of molecular mechanisms in disease and informed the development of therapeutic strategies. Dr. Abdelbaky’s technical expertise and commitment to professional growth have earned him recognition within the scientific community. His multifaceted career reflects a blend of academic excellence, research innovation, and leadership, making him a valuable asset to any institution and a strong candidate for accolades such as the Best Researcher Award.

Publications Top Notes

  1. Title: Enhanced sensitivity to hydrogen peroxide-induced apoptosis in Evi1 transformed Rat1 fibroblasts due to repression of carbonic anhydrase III
    Authors: Roy P, Reavey E, Rayne M, Roy S, Abed El Baky M, Ishii Y, Bartholomew C
    Year: 2010

  2. Title: BCR-ABL1 tyrosine kinase sustained MECOM expression in chronic myeloid leukaemia
    Authors: Roy S, Jørgensen HG, Roy P, Abed El Baky M, Melo JV, Strathdee G, Holyoake TL, Bartholomew C
    Year: 2012

  3. Title: Potential impact of urocortin I on sperm count, motility and sex hormone profiles in normal adult rats
    Authors: Hany A. El Kattawy, Mahmoud A. Naga, Ahmed Shata, Mohamed A. Elbaky
    Year: 2016

  4. Title: PTEN/PI3K/VEGF signaling pathway involved in the protective effect of xanthine oxidase inhibitor febuxostat against endometrial hyperplasia in rats
    Authors: MZ Mohamed, MF Abed El Baky, OA Hassan, HH Mohammed, AM Abdel-Aziz
    Year: 2020

  5. Title: The relation between ACKR4 and CCR7 genes expression and breast cancer metastasis
    Authors: Mostafa M. Mohammed, Olfat Shaker, Maggie M. Ramzy, Shereen S. Gaber, Heba S. Kamel, Mohamed F. Abed EL Baky
    Year: 2021

  6. Title: Aprepitant exerts anti-fibrotic effect via inhibition of TGF-β/Smad3 pathway in bleomycin-induced pulmonary fibrosis in rats
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Merhan E. Ali, Heba M. Hafez
    Year: 2022

  7. Title: Mirabegron alleviates acetic acid-induced colitis in rats: role of adiponectin and GSTM1/GSH detoxification pathway
    Authors: Mervat Z. Mohamed, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Heba M. Hafez
    Year: 2023

  8. Title: Cardioprotective effect of Ginger in a rat model of myocardial damage and its possible intervention in PERK-ATF4-CHOP-PUMA apoptotic pathway
    Authors: M. M. Mohammed, N. A. A. Osman, F. M. Moura, M. F. Abedelbaky
    Year: 2023

  9. Title: Vinpocetine alleviates valproic acid-induced hepatotoxicity and neurotoxicity through activation of cAMP and PI3K/AKT/CREB pathway in rats
    Authors: Heba M. Hafez, Mohamed F. Abed El Baky, Sahar A. Mokhemer, Salma M. Hassan, Mervat Z. Mohamed
    Year: Under submission (anticipated 2024 or 2025)

Yongpan An | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Yongpan An | Pharmaceutical Science | Best Researcher Award

Pharmacology Researcher from Xi’an People’s Hospital (Xi’an Fourth Hospital), China

Yongpan An is an emerging researcher in the field of pharmacology, specializing in drug screening and the mechanistic study of aging and aging-related diseases. A recent Ph.D. graduate from Peking University, Dr. An has demonstrated significant promise through his contributions to high-impact research, authoring and co-authoring several peer-reviewed publications. His work spans various disciplines, including molecular biology, artificial intelligence, and pharmacological intervention, reflecting a multidisciplinary approach essential for innovative biomedical research. As of now, he is affiliated with Xi’an People’s Hospital, where he continues to build on his doctoral research. Dr. An has already co-authored influential studies published in journals such as Nature Biotechnology, Aging Cell, Frontiers in Pharmacology, and Life Medicine. Despite being early in his career, his scientific output, collaboration with renowned researchers, and peer review responsibilities signal a strong foundation for a successful academic trajectory. His research addresses a critical area in medical science—aging—and aims to identify compounds that can prolong lifespan and reduce age-associated degeneration. With demonstrated leadership in co-authorship roles and contributions to the understanding of pharmacological interventions for aging, Yongpan An stands out as a dedicated, capable, and innovative young scientist poised for further accomplishments.

Professional Profile

Education

Yongpan An’s academic journey reflects a solid foundation in biotechnology and pharmacology, cultivated through rigorous training at leading Chinese institutions. He began his undergraduate studies in Biotechnology at Yunnan University, where he developed fundamental skills in molecular biology and biochemical research. From 2014 to 2018, he was immersed in coursework and research that exposed him to laboratory techniques and foundational knowledge in life sciences. His pursuit of advanced studies led him to Peking University, one of China’s most prestigious academic institutions, where he obtained his Ph.D. in Pharmacology between 2018 and 2023. At Peking University, under the mentorship of Dr. Zhengwei Xie, he focused on drug screening and the molecular mechanisms underlying aging. During this period, Dr. An gained hands-on experience with advanced pharmacological methodologies, contributing to several high-impact studies. His doctoral training not only equipped him with scientific expertise but also fostered skills in critical thinking, interdisciplinary collaboration, and scientific communication. His research incorporated cutting-edge areas such as the application of artificial intelligence in drug discovery, reinforcing the modern relevance of his education. This academic progression—from biotechnology to pharmacology—provides a robust framework for his current and future research endeavors in aging and age-related diseases.

Professional Experience

Dr. Yongpan An is currently employed at Xi’an People’s Hospital, where he continues to engage in pharmacological research with a focus on aging and age-related diseases. Although early in his professional career, Dr. An has already demonstrated remarkable productivity and leadership in scientific research. During his doctoral studies at Peking University, he was deeply involved in collaborative projects that combined pharmacological experimentation with computational analysis. His work involved both in vivo and in vitro models, providing him with experience across various experimental platforms. In addition to research responsibilities, Dr. An served as a reviewer for the journal Pharmacological Research, evaluating scientific manuscripts and gaining familiarity with the editorial and peer-review process. His professional engagements have also included active participation in scientific conferences and forums, where he presented his findings and interacted with experts in the field of aging and pharmacology. Notably, he played a major role in authoring a comprehensive review titled The Landscape of Aging, where he was responsible for summarizing the application of artificial intelligence in anti-aging drug discovery. As he transitions from a student to an independent researcher, Dr. An continues to demonstrate commitment to excellence, innovation, and scientific rigor in his ongoing professional endeavors.

Research Interests

Dr. Yongpan An’s primary research interests lie in the pharmacological modulation of aging and the discovery of novel compounds targeting aging-related diseases. His work integrates drug screening techniques with the mechanistic study of cellular and organismal aging processes. Specifically, he is interested in understanding how small molecules interact with key molecular pathways, such as the AKT signaling cascade, p16, and cyclin regulatory mechanisms, to delay senescence and promote healthy lifespan extension. Another key area of interest for Dr. An is the use of natural products, such as oridonin and berberine, in regulating cellular aging. His contributions to this field are evident from his publications in high-impact journals that explore the therapeutic potential of such compounds in mouse and yeast models. Additionally, he has contributed to the development of AI-driven tools for predicting drug efficacy from transcriptional profiles, showcasing his interest in computational pharmacology. The integration of artificial intelligence and deep learning with experimental pharmacology highlights his vision of combining traditional experimental approaches with cutting-edge digital methodologies. His overarching goal is to discover and validate compounds that not only extend lifespan but also improve quality of life by mitigating the effects of chronic and degenerative diseases associated with aging.

Research Skills

Dr. Yongpan An possesses a diverse and interdisciplinary set of research skills, developed through years of academic training and hands-on laboratory experience. He is proficient in a wide range of pharmacological and molecular biology techniques, including cell culture, Western blotting, immunofluorescence, RNA extraction, and quantitative PCR. He has extensive experience working with animal models, especially in the context of lifespan and senescence studies in mice and yeast, which are central to his research in aging. His capabilities also include the screening and identification of bioactive compounds using high-throughput methods, allowing him to evaluate the pharmacodynamic and pharmacokinetic properties of candidate molecules. Dr. An is adept at using bioinformatics and artificial intelligence tools to analyze gene expression data and predict drug responses. This skillset was crucial in his involvement in the development of deep learning models for drug efficacy prediction, published in Nature Biotechnology. Moreover, his experience as a peer reviewer reflects his ability to critically assess scientific literature and evaluate experimental design, data quality, and interpretation. His collaborative skills and familiarity with interdisciplinary projects further enhance his research capabilities, making him an asset to both academic and clinical research teams focusing on anti-aging pharmacological interventions.

Awards and Honors

Despite being at the beginning of his career, Dr. Yongpan An has already received several prestigious awards in recognition of his academic excellence and research achievements. During his doctoral studies at Peking University, he was honored with the National Scholarship, a highly competitive award given to outstanding students in China. He also received the First Prize in the Soaring Young Scholar competition held by Northwestern Polytechnical University, which recognizes young researchers for innovative scientific contributions. Additionally, he was awarded the Second Prize at the Young Scientist Forum Report organized by the Beijing Society of Pharmacology and Physiological Sciences, affirming his potential as a promising figure in pharmacological research. These honors not only reflect his dedication to scientific inquiry but also underscore the impact and relevance of his work within the research community. His involvement as a co-first author in significant collaborative publications further demonstrates peer recognition of his scholarly efforts. Beyond awards, his service as a manuscript reviewer for an established journal like Pharmacological Research highlights the trust placed in his scientific judgment. Collectively, these accolades validate Dr. An’s emerging role as a capable and committed young scientist with a promising future in pharmacology and aging research.

Conclusion

In summary, Dr. Yongpan An embodies the qualities of a highly promising early-career researcher with a strong academic foundation, impactful research output, and growing recognition within the scientific community. His work focuses on one of the most critical areas in medical science—understanding and intervening in the aging process to improve human health and longevity. His background in both experimental pharmacology and artificial intelligence places him at the intersection of innovation and translational medicine. Despite his relatively recent graduation, he has already authored multiple first-author publications, participated in high-level collaborative research, and received awards for his contributions. Dr. An’s dedication to advancing the pharmacological understanding of aging-related diseases and his proactive engagement in academic publishing and peer review highlight his scientific maturity. He is currently well-positioned to expand his research, attract future funding, and lead independent projects that will further enhance his professional profile. As he continues to build his research portfolio at Xi’an People’s Hospital, Dr. An is likely to contribute significantly to the development of therapeutic strategies that target aging and its associated disorders. Therefore, he represents an outstanding candidate for recognition through awards that honor excellence in scientific research.

Publications Top Notes

  1. Title: Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy
    Authors: Gao, Ke; Xi, Wenjin; Ni, Jianxin; Zhang, Rui; Wu, Guojun
    Journal: Biomaterials
    Year: 2025

Bogdan -Stefan Negreanu-Pirjol | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Bogdan -Stefan Negreanu-Pirjol | Pharmaceutical Science | Best Researcher Award

Head of Analytical and Instrumental Chemistry at Ovidius University of Constanta, Romania

Assoc. Prof. Dr. Bogdan-Ștefan Negreanu-Pîrjol is a distinguished academic and researcher, celebrated for his innovative contributions to the fields of analytical chemistry and pharmacy. With a prolific career spanning over two decades, Dr. Negreanu-Pîrjol has made significant advancements in biocomposites, pharmaceutical formulations, and instrumental analysis. His dedication to education, research, and mentorship has solidified his reputation as a leader in his field. He has published extensively, obtained numerous patents, and played a pivotal role in shaping the next generation of professionals and researchers through his teaching and collaborative initiatives.

Professional Profile

Education

Dr. Negreanu-Pîrjol earned his Ph.D. in Chemistry from the University of Bucharest, with groundbreaking research on biocomposite fertilizers that showcased his ability to merge scientific innovation with practical application. He also holds a Habilitation Certificate in Pharmacy from Ovidius University of Constanța, enabling him to mentor doctoral students and lead advanced research projects. His academic journey began with a Bachelor’s degree in Chemistry, where he excelled in both theoretical and practical aspects of the discipline. Over the years, he has further enhanced his expertise through certifications in environmental auditing, project management, and laboratory quality control, reflecting his commitment to lifelong learning.

Professional Experience

Dr. Negreanu-Pîrjol has held multiple influential positions at Ovidius University of Constanța, where he currently serves as an Associate Professor in the Faculty of Pharmacy. His teaching portfolio includes courses in analytical chemistry, instrumental analysis, and quality control, tailored to meet the needs of pharmacy students. Beyond academia, he has contributed to numerous industry projects, serving as a consultant and scientific officer in areas such as environmental monitoring and pharmaceutical product development. His leadership in funded research projects and his role as a reviewer for high-impact journals highlight his standing as a respected expert in his field.

Research Interests

Dr. Negreanu-Pîrjol’s research interests encompass a wide range of topics within chemistry and pharmacy. He is particularly focused on the development of biocomposite materials, innovative pharmaceutical formulations, and advanced analytical techniques. His interdisciplinary approach often bridges chemistry with environmental science and healthcare, aiming to create sustainable solutions and improve patient outcomes. He is also deeply interested in exploring the applications of nanotechnology and artificial intelligence in pharmaceutical sciences, which align with emerging trends and global research priorities.

Research Skills

Dr. Negreanu-Pîrjol possesses exceptional skills in analytical and instrumental chemistry, with expertise in techniques such as chromatography, spectroscopy, and electrochemical analysis. He is also proficient in designing and executing complex experiments, data interpretation, and statistical analysis. His innovative mindset is evident in his 16 patents and numerous peer-reviewed publications, which demonstrate his ability to translate theoretical concepts into practical applications. Additionally, his experience in project management and grant writing has enabled him to lead multidisciplinary teams and secure funding for impactful research projects.

Awards and Honors

Dr. Negreanu-Pîrjol’s contributions to science and education have been recognized through various awards and honors. He has received accolades for his research excellence, including national and international distinctions for his work on biocomposite materials and pharmaceutical innovations. His role as a mentor has also been acknowledged through teaching awards, reflecting his commitment to nurturing talent and fostering academic excellence. Furthermore, his patents and publications have earned him a reputation as a trailblazer in his field, cementing his legacy as a thought leader.

Conclusion

Assoc. Prof. Dr. Bogdan-Ștefan Negreanu-Pîrjol exemplifies the qualities of an outstanding researcher, educator, and innovator. His extensive academic background, prolific research output, and unwavering dedication to advancing science make him a worthy candidate for prestigious recognitions like the Best Researcher Award. By integrating cutting-edge technologies with practical applications, he continues to contribute to the betterment of society while inspiring future generations of scientists and professionals.

Publication Top Notes

  1. Title: Aquatic plants used for heavy metals phytoaccumulation and phytoremediation potential: A review
    Authors: Negreanu-Pirjol, B.-S., Popovidu, D.R., Negreanu-Pirjol, T.
    Year: 2024
  2. Title: The Chemical Profile, Antioxidant, and Anti-Lipid Droplet Activity of Fluid Extracts from Romanian Cultivars of Haskap Berries, Bitter Cherries, and Red Grape Pomace for the Management of Liver Steatosis
    Authors: Craciunescu, O., Seciu-Grama, A.-M., Mihai, E., Ranca, A., Negreanu-Pirjol, B.-S.
    Year: 2023
  3. Title: Natural Bio-Compounds from Ganoderma lucidum and Their Beneficial Biological Actions for Anticancer Application: A Review
    Authors: Cadar, E., Negreanu-Pirjol, T., Pascale, C., Tomescu, C.L., Ionescu, A.-M.
    Year: 2023
  4. Title: Biocompounds from Green Algae of Romanian Black Sea Coast as Potential Nutraceuticals
    Authors: Cadar, E., Negreanu-Pirjol, T., Sirbu, R., Axente, E.R., Ionescu, A.-M.
    Year: 2023
  5. Title: Health Benefits of Antioxidant Bioactive Compounds in the Fruits and Leaves of Lonicera caerulea L. and Aronia melanocarpa (Michx.) Elliot
    Authors: Negreanu-Pirjol, B.-S., Oprea, O.C., Negreanu-Pirjol, T., Cosma, M., Popoviciu, D.R.
    Year: 2023
  6. Title: In Vitro Hypoglycemic Potential, Antioxidant and Prebiotic Activity after Simulated Digestion of Combined Blueberry Pomace and Chia Seed Extracts
    Authors: Mihai, E., Negreanu-Pirjol, B.-S., Craciunescu, O., Ghenea, A.-M., Negreanu-Pirjol, T.
    Year: 2023
  7. Title: Jellyfishes—Significant Marine Resources with Potential in the Wound-Healing Process: A Review
    Authors: Cadar, E., Pesterau, A.-M., Sirbu, R., Negreanu-Pirjol, B.S., Tomescu, C.L.
    Year: 2023
  8. Title: Xanthophyll pigments dietary supplements administration and retinal health in the context of increasing life expectancy trend
    Authors: Jurja, S., Negreanu-Pirjol, T., Vasile, M., Coviltir, V., Negreanu-Pirjol, B.-S.
    Year: 2023
  9. Title: Preliminary Data Regarding Bioactive Compounds and Total Antioxidant Capacity of Some Fluid Extracts of Lonicera caerulea L. Berries
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Motelica, L., Vasile, M.
    Year: 2023
  10. Title: Marine Bioactive Compounds Derived from Macroalgae as New Potential Players in Drug Delivery Systems: A Review
    Authors: Negreanu-Pirjol, B.-S., Negreanu-Pirjol, T., Popoviciu, D.R., Anton, R.-E., Prelipcean, A.-M.
    Year: 2022

 

 

Ermin Schadich | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Ermin Schadich | Pharmaceutical Science | Best Researcher Award

Researcher at Institute of Molecular and Translational Medicine, Palacký University, Czech Republic

Dr. Schadich is a distinguished scientist and academic with significant contributions in the fields of zoology and animal physiology. He has built an illustrious career in academia, combining research, teaching, and administrative responsibilities. Dr. Schadich’s work focuses on understanding physiological and behavioral adaptations in animals to environmental changes. Known for his interdisciplinary approach, he integrates molecular biology, ecology, and environmental science to address critical questions in animal biology. Dr. Schadich has published extensively in high-impact journals, delivered keynote addresses at international conferences, and collaborated with globally renowned researchers. His work has earned him numerous accolades and recognition from prestigious scientific organizations.

Professional Profile

Education

Dr. Schadich holds a Ph.D. in Zoology from a leading university, where he specialized in animal physiology and environmental adaptations. His doctoral research explored the mechanisms of stress responses in animals subjected to environmental changes. Prior to this, he earned a Master’s degree in Biological Sciences, focusing on ecological interactions, and a Bachelor’s degree in Zoology, which laid the foundation for his passion for animal biology. Throughout his education, Dr. Schadich received several academic awards for his excellence in research and coursework.

Professional Experience

Dr. Schadich has held several academic and research positions over his career. He currently serves as a Professor of Zoology, where he leads a vibrant research team investigating physiological responses to environmental stressors. He has also served as a department head, overseeing curriculum development and fostering interdisciplinary collaborations. Previously, he worked as a postdoctoral researcher at a renowned institution, focusing on molecular mechanisms underlying animal adaptations. Dr. Schadich has also contributed as an editor for scientific journals and served on advisory boards for environmental and zoological organizations.

Research Interests

Dr. Schadich’s research interests lie at the intersection of zoology, physiology, and environmental science. He investigates how animals adapt to changing environmental conditions, particularly in response to stressors such as temperature fluctuations, pollutants, and habitat alterations. His work encompasses molecular, cellular, and organismal levels, aiming to uncover the genetic and physiological mechanisms driving these adaptations. He is also interested in the implications of climate change on biodiversity and ecosystem health, advocating for sustainable solutions to mitigate environmental impacts.

Research Skills

Dr. Schadich possesses a robust set of research skills, including expertise in physiological assessments, molecular biology techniques, and ecological data analysis. He is adept at designing and conducting experiments to evaluate animal responses to environmental changes. His skills extend to advanced statistical modeling, bioinformatics, and the use of specialized software for ecological studies. Dr. Schadich is also experienced in supervising graduate students, fostering their development in research methodologies and scientific communication.

Awards and Honors

Dr. Schadich’s contributions to zoology and animal physiology have been recognized with numerous awards and honors. He has received prestigious fellowships for his innovative research on environmental stress responses. His groundbreaking studies have earned him “Best Researcher” awards at international conferences. Additionally, Dr. Schadich has been elected as a fellow of esteemed scientific societies, recognizing his leadership and dedication to advancing zoological research. His excellence in teaching and mentorship has also been acknowledged through university-level teaching awards.

Conclusion 🏆

Dr. Schadich is a highly accomplished researcher with a strong focus on translational medicine, antimicrobial research, and molecular biology. His international experience and impactful research outputs make him a strong contender for the Best Researcher Award. Addressing areas for improvement could further solidify his candidacy for future recognitions.

Publication Top Notes

  1. Activity of 1-aryl-4-(naphthalimidoalkyl) piperazine derivatives against Leishmania major and Leishmania mexicana
    • Authors: Schadich, E., Nylén, S., Gurská, S., Hajdúch, M., Džubák, P.
    • Year: 2022
    • Journal: Parasitology International
    • Citations: 3
  2. Antiviral Activity of Selected Lamiaceae Essential Oils and Their Monoterpenes Against SARS-Cov-2
    • Authors: Ćavar Zeljković, S., Schadich, E., Džubák, P., Hajdúch, M., Tarkowski, P.
    • Year: 2022
    • Journal: Frontiers in Pharmacology
    • Citations: 36
  3. Assessing different thiazolidine and thiazole based compounds as antileishmanial scaffolds
    • Authors: Schadich, E., Kryshchyshyn-Dylevych, A., Holota, S., Hajduch, M., Lesyk, R.
    • Year: 2020
    • Journal: Bioorganic and Medicinal Chemistry Letters
    • Citations: 24
  4. Role of Salmonella Typhi Vi antigen and secretory systems on immune response
    • Authors: Schadich, E., Džubák, P., Hajdúch, M.
    • Year: 2016
    • Journal: Current Pharmaceutical Design
    • Citations: 13
  5. Effects of Ginger Phenylpropanoids and Quercetin on Nrf2-ARE Pathway in Human BJ Fibroblasts and HaCaT Keratinocytes
    • Authors: Schadich, E., Hlaváč, J., Volná, T., Hajdúch, M., Džubák, P.
    • Year: 2016
    • Journal: BioMed Research International
    • Citations: 54
  6. Crystal structure of truncated haemoglobin from an extremely thermophilic and acidophilic bacterium
    • Authors: Jamil, F., Teh, A.-H., Schadich, E., Najimudin, N., Alam, M.
    • Year: 2014
    • Journal: Journal of Biochemistry
    • Citations: 8
  7. Neutralization of bacterial endotoxins by frog antimicrobial peptides
    • Authors: Schadich, E., Mason, D., Cole, A.L.
    • Year: 2013
    • Journal: Microbiology and Immunology
    • Citations: 12
  8. Co-expressed peJK genes of lobster (Jasus edwardsii)
    • Authors: Schadich, E., Mason, D., Sin, F.
    • Year: 2012
    • Journal: Australian Journal of Zoology
    • Citations: 1
  9. Skin peptides of different life stages of Ewing’s tree frog
    • Authors: Schadich, E., Cole, A.L.J., Squire, M., Mason, D.
    • Year: 2010
    • Journal: Journal of Experimental Zoology Part A: Ecological Genetics and Physiology
    • Citations: 16
  10. Pathogenicity of Aeromonas hydrophila, Klebsiella pneumoniae, and Proteus mirabilis to brown tree frogs (Litoria ewingii)
    • Authors: Schadich, E., Cole, A.L.J.
    • Year: 2010
    • Journal: Comparative Medicine
    • Citations: 28

 

 

Shweta Mishra | Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

MS. Shweta Mishra | Toxicology and Pharmaceutical Science | Best Researcher Award

Student, K B institute of pharmaceutical education and research , India

Miss Shweta Mishra is a strong candidate for the Best Researcher Award, showcasing a solid educational background in pharmacy, including a Master’s degree in Quality Assurance and ongoing Ph.D. studies. Her research focuses on the development of chromatographic methods and stability studies of pharmaceutical compounds, with significant publications in reputable journals. With over six years of experience as a QC/ADL Manager at Molecule Laboratory, she has demonstrated her practical expertise in quality control and analytical development. Her responsibilities include sampling, analysis, and managing sophisticated analytical instruments like HPLC and LC-MS/MS, highlighting her leadership and technical skills. Shweta’s strong analytical capabilities, adherence to good laboratory practices (GLP), and proficiency in English and Hindi enhance her communication and collaboration skills in research settings. Overall, her academic achievements, impactful research, and extensive professional experience position her as an exceptional candidate deserving of this prestigious award.

Profile:

Education

Miss Shweta Mishra has established a strong educational foundation in the field of pharmacy. She is currently pursuing a Doctor of Philosophy at Kadi Sarva Vishwavidyalaya, showcasing her commitment to advanced research and academic excellence. Prior to her doctoral studies, she earned a Master of Pharmacy in Quality Assurance from Gujarat Technological University, where she achieved a first-class percentage of 70.10%. Her academic journey began with a Bachelor of Pharmacy from the same university, graduating with distinction at 76.00%. Shweta’s education is complemented by her high school achievements, where she also secured distinction in both HSC and SSC examinations. Her robust academic background, characterized by consistently high performance, reflects her dedication to understanding complex pharmaceutical concepts and her aspiration to contribute meaningfully to the field. This strong foundation has equipped her with the necessary skills and knowledge to excel in her research endeavors.

Professional Expereince

Miss Shweta Mishra has accumulated over six years of experience as a QC/ADL Manager at Molecule Laboratory, where she has demonstrated exceptional expertise in quality control and analytical development. Her role involves overseeing the sampling and analysis of raw materials and finished products, ensuring compliance with standard specifications and Good Laboratory Practices (GLP). Shweta effectively coordinates with QC executives and officers to fulfill QC activities and manages stability study samples, maintaining accurate records throughout the process. She is skilled in handling advanced analytical instruments, including HPLC and LC-MS/MS, and prepares analytical method validation protocols and reports. Her meticulous approach includes reviewing logbooks, calibrating instruments, and verifying data integrity for both raw materials and finished goods. This hands-on experience has honed her technical skills and leadership abilities, positioning her as a key player in maintaining the quality standards necessary for successful pharmaceutical research and development.

Research Skill

esearch skills are essential for effectively gathering, analyzing, and interpreting information across various disciplines. Key components of strong research skills include critical thinking, which enables researchers to evaluate sources and discern credible information; analytical skills for breaking down complex data; and attention to detail to ensure accuracy in findings. Proficiency in various research methodologies, including qualitative and quantitative approaches, is vital for selecting the appropriate methods to address specific questions. Additionally, effective communication skills are crucial for presenting research findings clearly and persuasively, whether in written reports or oral presentations. Familiarity with digital tools and databases enhances the ability to efficiently locate and manage information. Overall, a robust set of research skills empowers individuals to contribute meaningfully to their fields, driving innovation and advancing knowledge while fostering a systematic approach to problem-solving.

Award and Recognition

Miss Shweta Mishra’s dedication to research in the field of pharmacy, particularly in quality assurance and analytical development, has distinguished her as an exemplary candidate for the Best Researcher Award. Her academic journey, marked by a Master’s degree in Quality Assurance and ongoing Ph.D. studies, reflects her commitment to advancing pharmaceutical sciences. Shweta’s innovative research projects, including her published works on chromatographic methods and stability studies of pharmaceutical compounds, showcase her ability to contribute significant knowledge to the industry. With over six years of professional experience as a QC/ADL Manager at Molecule Laboratory, she has honed her skills in quality control and analytical methodologies, demonstrating leadership and technical proficiency. Her strong analytical skills and adherence to good laboratory practices further enhance her capabilities. Recognizing Miss Shweta Mishra with the Best Researcher Award would not only honor her individual achievements but also inspire others in the field to pursue excellence in research and development.

Conclusion

Miss Shweta Mishra is an exemplary candidate for the Best Researcher Award, demonstrating a robust combination of education, research contributions, and professional experience. Currently pursuing her Ph.D., she has a solid academic background with a Master’s in Quality Assurance, reflecting her commitment to advancing knowledge in pharmaceutical sciences. Her research projects, focusing on chromatographic methods and stability studies, have resulted in publications in reputable journals, showcasing her ability to contribute significantly to her field. With over six years of experience as a QC/ADL Manager at Molecule Laboratory, Shweta has developed practical expertise in quality control and analytical development, handling advanced instruments such as HPLC and LC-MS/MS. Her strong analytical skills, coupled with her adherence to good laboratory practices, further highlight her capabilities. Overall, Miss Shweta Mishra’s qualifications and contributions make her an outstanding choice for the award, as she embodies the dedication and excellence that the recognition seeks to honor.

Publication Top Notes

  • Lean systems: Applications and case studies in manufacturing, service, and healthcare
    • Authors: E.A. Cudney, S. Furterer, D. Dietrich
    • Year: 2013
    • Citations: 95
  • Growth of vertically aligned CdTe nanorod arrays through patterned electrodeposition
    • Authors: S. Mishra, M. Nath
    • Year: 2013
    • Citations: 28
  • Synthesis of superconducting nanocables of FeSe encapsulated in carbonaceous shell
    • Authors: S. Mishra, K. Song, J.A. Koza, M. Nath
    • Year: 2013
    • Citations: 22
  • Inorganic particulates in removal of toxic heavy metal ions: VIII. Removal of zinc, cadmium and mercury ions from aqueous solution by hydrous titanium oxide
    • Authors: S.P. Mishra, V.K. Singh
    • Year: 1999
    • Citations: 21*
  • Ascorbic acid requirement of catfish fry Clarias batrachus (Linn.)
    • Authors: S. Mishra, P.K. Mukhopadhyay
    • Year: 1996
    • Citations: 20
  • A kinetic study for in-vitro intestinal uptake of monosaccharide across rat everted gut sacs in the presence of some antidiabetic medicinal plants
    • Authors: M. Patel, S. Mishra
    • Year: 2009
    • Citations: 18
  • Enhancement of Superconducting Tc (33 K) by Entrapment of FeSe in Carbon Coated Au–Pd17Se15 Nanoparticles
    • Authors: S. Mishra, K. Song, K.C. Ghosh, M. Nath
    • Year: 2014
    • Citations: 16
  • Vertebral osteomyelitis and epidural abscesses caused by Prevotella oralis: a case report
    • Authors: H. Goyal, S. Arora, S. Mishra, S. Jamil, U. Shah
    • Year: 2012
    • Citations: 16
  • Biosorptive behavior of mango (Mangifera indica) and neem (Azadirachta indica) barks for 134Cs from aqueous solutions: A radiotracer study
    • Authors: S.P. Mishra, D. Tiwari, S.K. Prasad, R.S. Dubey, M. Mishra
    • Year: 2007
    • Citations: 14
  • Comparative analysis of wear behavior of garnet and fly ash reinforced Al7075 hybrid composite
    • Authors: S. Mishra, A. Patnaik, S.R. Kumar
    • Year: 2019
    • Citations: 13

Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Published on by Shen Awards

 Dr. Alaa Alsalloum | Immunology and Microbiology | Excellence in Research

Dr. Alaa Alsalloum, Novosibirsk State University, Russia.

Dr. Alaa Alsalloum is a dedicated researcher in the fields of immunology and microbiology, known for her contributions to understanding immune responses and microbial interactions. With a strong commitment to excellence in research, she focuses on innovative approaches to tackle infectious diseases and enhance immunological health. Alaa’s work is characterized by a collaborative spirit and a passion for advancing scientific knowledge, making her a valuable asset in the pursuit of breakthroughs in health and disease management.

Profile:

Education

Alaa Alsalloum’s educational journey began at the National Center for Distinguished in Syria, where she completed high school from October 2011 to June 2014. She then earned her Bachelor of Science in Pharmacy from the University of Damascus, focusing on Biomedical Sciences, with a thesis titled “Phage Nanobody Immuno-PCR for Ultra-sensitive Detection of Growth Hormone (GH).” Following this, Alaa participated in a general education program at Kazan (Volga Region) Federal University to master professional educational programs in Russian from October 2018 to June 2019. She continued her studies at Kazan Federal University, where she completed her master’s degree in the Institute of Medicine and Biology, focusing on the earlier immune markers of multiple sclerosis in an animal model for her thesis. Currently, Alaa is pursuing her PhD at Novosibirsk State University, specializing in molecular immunology, with her research centered on the phenotypic and functional characteristics of T-lymphocytes with genetically modified antigen-recognizing receptors specific to solid tumor antigens.

 Interests

Alaa Alsalloum is committed to community service, having volunteered with the Association for Persons with Special Needs (APSN) in Deir Atiyah, Syria, from July 2014 to September 2015. During her time there, she contributed to supporting individuals with special needs, helping to enhance their quality of life and promote inclusivity. This experience reflects her dedication to making a positive impact in the lives of others and highlights her passion for service beyond her academic pursuits.

 Skills

Alaa Alsalloum possesses a robust set of technical skills acquired through her research in immunology and molecular biology during her Bachelor’s and Master’s theses. She is proficient in DNA and RNA extraction, PCR, electrophoresis, bacterial transformation, ELISA tests, immunochemistry, NanoString technology, and cell culture techniques. Additionally, she has experience with PBMC isolation, viral transduction of T-lymphocytes, dendritic cell differentiation protocols, tetramer assays, cell sorting protocols, flow cytometry, and intracellular flow cytometry staining. Alaa also has foundational knowledge in RT-PCR, cell analysis, Seahorse technology, 3D cell culture, and single-cell sequencing.On the interpersonal side, she has developed strong presentation and communication skills through participation in various seminars focused on communication and leadership. Alaa is adept at collaborating within a team while also demonstrating the ability to work independently, making her a well-rounded candidate in both research and professional settings.

 

Publication Top Notes

Alsalloum, A. (2024). NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy. Clinical and Translational Medicine. DOI: 10.1002/ctm2.70020. ISSN: 2001-1326.

Alsalloum, A. (2023). TCR-Engineered Lymphocytes Targeting NY-ESO-1: In Vitro Assessment of Cytotoxicity against Tumors. Biomedicines, 11(10), Article 2805. DOI: 10.3390/biomedicines11102805.

Alsalloum, A. (2023). Exploring TCR-like CAR-Engineered Lymphocyte Cytotoxicity against MAGE-A4. International Journal of Molecular Sciences, 24(20), Article 15134. DOI: 10.3390/ijms242015134.

Alsalloum, A. (2023). Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow. PLOS ONE, 18(6), Article e0287793. DOI: 10.1371/journal.pone.0287793. ISSN: 1932-6203.

Alsalloum, A. (2023). The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Cancers, 15(6), Article 1779. DOI: 10.3390/cancers15061779.

Alsalloum, A. (2022). Phenotypic and functional features of in vitro generated TCR-T cells specific for the tumor-associated antigen NY-ESO-1. Immunologiya, 43(5), 536-547. DOI: 10.33029/0206-4952-2022-43-5-536-547.

Alsalloum, A. (2022). Study of MAGE-A4 specific TCR-like CAR-T lymphocytes in vitro. Immunologiya, 43(4), 401-411. DOI: 10.33029/0206-4952-2022-43-4-401-411.

Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

Published on by Shen Awards

Assoc Prof Dr. Omar Ahmed-Farid | Toxicology and Pharmaceutical Science | Life Sciences Innovation Award

2004, EDA, Egypt

Dr. Omar Abdel-Hamed Ahmed-Farid is a highly qualified candidate for the Research for Best Researcher Award. With a robust academic and professional background, Dr. Farid has significantly impacted the field of physiology and analytical chemistry. His impressive citation metrics—1889 citations, an H-index of 24, and an I10-index of 61—highlight his influential research. As the Unit Administration Manager at the Egyptian Drug Authority, he excels in regulatory compliance, quality assurance, and team leadership. His previous roles include Technical Manager and Drug Quality Control Specialist, where he managed laboratory practices and ensured adherence to international standards. Dr. Farid’s contributions to policy development and staff training further demonstrate his dedication to advancing industry standards and professional excellence. His extensive research experience, combined with his leadership in regulatory and quality assurance roles, makes him a strong contender for this award.

Profile:

Education

Dr. Omar Abdel-Hamed Ahmed-Farid has a distinguished educational trajectory that underscores his expertise in physiology and analytical chemistry. He began his academic journey as an Assistant Researcher in Physiology in 2005, gradually advancing through roles as an Assistant Researcher, Researcher, and ultimately becoming an Associate Professor of Physiology in 2020. His progression reflects a deepening of knowledge and a growing commitment to the field. Dr. Farid’s education has been marked by hands-on experience and rigorous training in high-performance analytical techniques, such as High-Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC). This solid educational foundation has been instrumental in his success in research, quality assurance, and regulatory compliance within the pharmaceutical and medical diagnostics sectors. His academic background is a testament to his dedication to advancing scientific knowledge and improving industry standards

Professional Experience

Dr. Omar Abdel-Hamed Ahmed-Farid’s professional experience showcases a profound impact on the fields of physiology and analytical chemistry. As the Unit Administration Manager of Diagnostic Kits and Medical Supplies at the Egyptian Drug Authority (EDA), he oversees regulatory compliance, quality assurance, and documentation, ensuring adherence to national and international standards. His previous role as Technical Manager involved the implementation and maintenance of ISO-17025 and GLP standards, critical for maintaining laboratory accuracy and reliability. Dr. Farid’s extensive experience also includes managing laboratory equipment procurement and validation, as well as training staff on analytical techniques and quality protocols. His contributions to policy development and regulatory practices highlight his leadership and commitment to advancing industry standards. His career trajectory, from Drug Quality Control Specialist to Associate Professor, reflects a deep and evolving expertise, underpinned by a dedication to both scientific excellence and professional development.

Research Skill

Dr. Omar Abdel-Hamed Ahmed-Farid possesses a robust set of research skills, underscored by his extensive experience and academic background. His proficiency in analytical techniques such as High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), and Spectrophotometry highlights his capability to conduct precise and comprehensive biochemical analyses. Dr. Farid has demonstrated expertise in determining neurotransmitters, amino acids, and cellular metabolites, utilizing advanced methods like Atomic Absorption Spectroscopy and ELISA techniques. His research includes investigating enzymatic and non-enzymatic antioxidants, analyzing tissue samples using the Comet Assay, and studying animal blood pressure. His ability to apply complex analytical methods and maintain high standards in research protocols is further evidenced by his contributions to method validation and compliance with international standards. Dr. Farid’s analytical skills, combined with his commitment to quality and innovation, underscore his exceptional research capabilities.

Award and Recognition

Dr. Omar Abdel-Hamed Ahmed-Farid has demonstrated exceptional expertise and dedication in the field of physiology and analytical chemistry, earning widespread recognition for his impactful research and professional contributions. With 1889 citations, an H-index of 24, and a Researchgate score of 46.42, his scholarly work has significantly influenced the scientific community. As the Unit Administration Manager at the Egyptian Drug Authority, Dr. Farid has excelled in ensuring regulatory compliance, maintaining high-quality standards, and leading a team dedicated to advancing diagnostic practices. His commitment to policy development, training, and innovation underscores his role as a pivotal figure in the industry. Dr. Farid’s achievements reflect a remarkable blend of academic excellence and practical impact, making him a distinguished candidate for the Research for Best Researcher Award.

Conclusion

Dr. Omar Abdel-Hamed Ahmed-Farid’s comprehensive research contributions, extensive professional experience, and leadership in regulatory and quality assurance roles make him a highly suitable candidate for the Research for Best Researcher Award. His impact on the field through his research, coupled with his commitment to advancing regulatory practices and training, aligns well with the criteria for this prestigious award.

Publication Top Notes

  • Publication Title: Recombinant Interleukin − 2 Immunotherapy Ameliorates Inflammation and Promotes the Release of Monoamine Neurotransmitters in the Gut-Brain Axis of Schistosoma mansoni-Infected Mice
    • Authors: Mehran, H.S., Nady, S., Kassab, R.B., Ahmed-Farid, O.A., El-Hennamy, R.E.
    • Journal: Journal of Neuroimmune Pharmacology
    • Year: 2024
    • Volume: 19
    • Issue: 1
    • Pages: 37
    • Citations: 0
  • Publication Title: Anti-depressant effect of Naringenin-loaded hybridized nanoparticles in diabetic rats via PPARγ/NLRP3 pathway
    • Authors: El-Marasy, S.A., AbouSamra, M.M., Moustafa, P.E., Galal, A.F., Farouk, H., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 13559
    • Citations: 0
  • Publication Title: The study of wound healing activity of Thespesia populnea L. bark, an approach for accelerating healing through nanoparticles and isolation of main active constituents
    • Authors: Abdel Halim, M.B., Eid, H.H., El Deeb, K.S., Ahmed-Farid, O.A., El Messiry, H.M.
    • Journal: BMC Complementary Medicine and Therapies
    • Year: 2024
    • Volume: 24
    • Issue: 1
    • Article Number: 85
    • Citations: 0
  • Publication Title: Eugenol alleviates acrylamide-induced rat testicular toxicity by modulating AMPK/p-AKT/mTOR signaling pathway and blood–testis barrier remodeling
    • Authors: Saleh, D.O., Baraka, S.M., Jaleel, G.A.A., Hassan, A., Ahmed-Farid, O.A.
    • Journal: Scientific Reports
    • Year: 2024
    • Volume: 14
    • Issue: 1
    • Article Number: 1910
    • Citations: 1
  • Publication Title: Gastro-Protective, Antioxidant, and Anti-Inflammatory Potential of Three Vegetable Oils Against Indomethacin-Induced Gastric Ulceration in Rats: in Vivo and in Vitro Study
    • Authors: Mohamed, M.M., Ahmed-Farid, O.A.
    • Journal: Egyptian Journal of Chemistry
    • Year: 2024
    • Volume: 67
    • Issue: 7
    • Pages: 341–359
    • Citations: 0
  • Publication Title: A combined administration of GABA agonist and L-histidine synergistically alleviates obesity-induced neuro-lipotoxicity and distorted metabolic transcriptome
    • Authors: Al-Malki, E.S., Ahmed-Farid, O.A., Moustafa, M.M.A., Linhardt, R.J., Warda, M.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02177
    • Citations: 0
  • Publication Title: Tolerability of Artemisia absinthium in anorexia: Targeting of neuronal appetite and satiety in zinc deficiency diet rat model
    • Authors: El-bakry, K.A.-E.K.M., Bahnasawy, M.H., Deef, L.E., Ahmed-Farid, O.A.-H., El-Naeli, S.S.B.
    • Journal: Scientific African
    • Year: 2024
    • Volume: 24
    • Article Number: e02162
    • Citations: 0
  • Publication Title: Zinc Oxide Nanoparticles Attenuated Neurochemical and Histopathological Alterations Associated with Aluminium Chloride Intoxication in Rats
    • Authors: Attia, F.M., Kassab, R.B., Ahmed-Farid, O.A., Abdel Moneim, A.E., El-Yamany, N.A.
    • Journal: Biological Trace Element Research
    • Year: 2024
    • Volume: (in press)
    • Citations: 0
  • Publication Title: Neurological study on the effect of CeNPs and/or La Cl3 on adult male albino rats
    • Authors: Abdel-Rahman, M., Elmasry, H.M., Ahmed-Farid, O.A., Hegazy, S.M., Rezk, M.M.
    • Journal: Journal of Trace Elements in Medicine and Biology
    • Year: 2024
    • Volume: 81
    • Article Number: 127323
    • Citations: 2
  • Publication Title: Nanoliposomal amino acids counteracting protein malnutrition induced hematopoietic and hepatic complications
    • Authors: Ahmed, R.F., Elbaset, M.A., Farouk, H., Ahmed-Farid, O.A.H., Nasr, M.
    • Journal: Journal of Drug Delivery Science and Technology
    • Year: 2023
    • Volume: 89
    • Article Number: 105051
    • Citations: 0

 

Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Prof. Bashige Chiribagula Valentin | Pharmaceutical Science | Best Researcher Award

Professor of UNILU, Congo.

Dr. Bashige Chiribagula Valentin is a prominent academic and researcher specializing in ethnopharmacology, medicinal chemistry, and quality control. Currently a professor at the University of Lubumbashi, he has held roles including department head, research specialist in pharmacognosy, and educator in pharmacology. His research focuses on the ethnobotanical, phytochemical, and pharmacological properties of medicinal plants, with significant contributions to the development of traditional medicine-based therapies, such as antimalarial and antimicrobial agents. Dr. Chiribagula has led various projects aimed at enhancing the quality and efficacy of herbal remedies and has published extensively in reputed journals. His work includes studies on plant-based treatments for malaria, diabetes, and wound healing, reflecting his commitment to integrating traditional knowledge with modern scientific approaches. His leadership in the academic and scientific community, coupled with his impactful research, underscores his candidacy for the Best Researcher Award.

Profile
Education

Dr. Bashige Chiribagula Valentin’s educational background is extensive and well-rounded. He earned his Doctorate in Pharmaceutical Sciences from the University of Lubumbashi (UNILU) and the Université de Mons (UMONS) in 2021, specializing in Pharmacognosy with a focus on ethnopharmacology. Prior to this, he obtained a Diplôme d’Études Approfondies in Pharmacognosy from UNILU in 2016. His foundational education includes a Diplôme de Pharmacie d’Industrie et Analyse de Médicaments from UNILU, completed in 2012, and a Diplôme d’Études Générales en Sciences Pharmaceutiques from the University of Kinshasa (UNIKIN) in 2006. His academic journey demonstrates a strong commitment to advancing knowledge in pharmaceutical sciences, particularly in the areas of pharmacognosy and ethnopharmacology.

Professional Experience

Dr. Bashige Chiribagula Valentin has an extensive and diverse professional background in the field of pharmacognosy and ethnopharmacology. He has served as a Professor at the University of Lubumbashi since 2022, where he also holds positions as President of juries and Secretary of the Department of Pharmacology. His career at the university began as an Assistant in 2013, progressing to a Chief of Works and Specialist in Pharmacognosy. In addition to his academic roles, Dr. Chiribagula has been actively involved in the pharmaceutical industry as a Quality Control Manager at PROMED Lubumbashi. His research focuses on ethnopharmacology, medicinal chemistry, and quality control of medicinal plants, contributing significantly to the development of traditional medicine projects. Dr. Chiribagula’s career also includes roles in secondary education and civil society, showcasing his dedication to both education and community service.

Research Interest

Dr. Bashige Chiribagula Valentin’s research focuses on the ethnopharmacological and medicinal properties of plants, particularly in the context of traditional medicine. His work spans the study of plant-based remedies for various diseases, including malaria and diabetes, with a strong emphasis on the pharmacognosy of medicinal plants. Dr. Chiribagula’s research integrates ethnobotanical surveys, phytochemical analysis, and pharmacological testing to explore and validate the therapeutic potential of natural substances. His projects include the development of medicinal plants for wound healing, anti-malarial, anti-ulcer, and antibacterial applications. Additionally, he investigates the nutritional and medicinal benefits of indigenous fungi, fruits, and vegetables. His research aims to bridge traditional knowledge with modern scientific validation, contributing to the development of effective, natural therapeutic agents and enhancing the quality of life in the Democratic Republic of Congo.

Research Skills

Dr. Bashige Chiribagula Valentin demonstrates a robust set of research skills essential for advancing his field of study. His expertise spans ethnopharmacology, medicinal chemistry, and quality control, with a strong emphasis on the pharmacognostic and phytochemical evaluation of medicinal plants. Dr. Chiribagula excels in employing various analytical techniques, including chromatography (TLC, Flash, HPLC), spectral analysis (MS), and microbiological assays (antimicrobial testing, antioxidant assays). His proficiency in using statistical software such as SPSS and GraphPad supports his rigorous data analysis. Additionally, he has a solid background in experimental design and execution, demonstrated by his work on traditional medicine and natural product research. His ability to integrate traditional knowledge with scientific methodologies underscores his contributions to the development of novel therapeutic agents and quality control measures in pharmaceuticals. Dr. Chiribagula’s comprehensive approach and methodological skills are integral to his research successes.

Awards and Recognition

Dr. Bashige Chiribagula Valentin has garnered significant recognition for his contributions to pharmacognosy and ethnopharmacology. He was honored as the “Major de Promotion” in 2012 and achieved notable accolades in 2019, securing first place at the MT180 regional AUF competition and second place at the national MT180 competition. His scholarly excellence is highlighted by his award-winning research on ethnobotanical studies and medicinal plants, which has been recognized in several prestigious journals. Dr. Chiribagula’s impactful work in the development of medicinal plant-based treatments, including those for malaria and wound healing, has further solidified his reputation in the scientific community. These awards underscore his dedication to advancing knowledge in pharmaceutical sciences and his commitment to improving public health through innovative research.

Conclusion

Bashige Chiribagula Valentin is a strong candidate for the Research for Best Researcher Award due to his substantial contributions to ethnopharmacology, his significant publications, and his active role in academia and the pharmaceutical industry. His expertise in traditional medicine and his impactful research on medicinal plants, coupled with his notable awards and professional experience, underline his qualifications for the award.

Publications Top Notes

  • Ethnomedical Knowledge of Plants Used in Nonconventional Medicine for Wound Healing in Lubumbashi, Haut‐Katanga Province, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2024
  • Ethnomedicinal Knowledge of Plants Used in Nonconventional Medicine in the Management of Diabetes Mellitus in Kinshasa (Democratic Republic of the Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2023
  • Ethnobotanical study of plants used by traditional healers in Lubumbashi (Democratic Republic of Congo) in the management of typhoid fever
    • Authors: Bashige Chiribagula Valentin
    • Year: 2022
  • Activité antioxydante de 53 plantes réputées antimalariques en République Démocratique du Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • In vitro antioxidant activity and in vivo aphrodisiac activity in male Cavia porcellus of Albizia adianthifolia (Schum.) W. Wight and Pericopsis angolensis (Baker) Meeuwen
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)
    • Authors: Bashige Chiribagula Valentin
    • Year: 2021
  • Antimicrobial, antioxidant activities and toxicity on Cavia porcellus of Dialium angolense Welw. Ex Oliv, a traditional medicinal plant from Bagira in Eastern of DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Ethnobotanical study of medicinal plants used in the treatment of sexual dysfunctions in traditional medicine in Kampemba-Lubumbashi, DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020
  • Antiplasmodial, antioxidant and toxicological study of leaves extracts of Dalbergia katangensis Lecheneaud (Fabaceae) from Eastern DR Congo
    • Authors: Bashige Chiribagula Valentin
    • Year: 2020

 

Xian Zheng | Pharmaceutical Science | Best Researcher Award

Published on by Shen Awards

Dr. Xian Zheng | Pharmaceutical Science | Best Researcher Award

Assistant research Fellow of Affiliated Kunshan Hospital of Jiangsu University, China.

Xian Zheng is a prominent researcher specializing in Chinese herbal drugs, natural products, and nonalcoholic fatty liver disease (NAFLD). With a Ph.D. in Chinese pharmacy from China Pharmaceutical University, he currently serves as an Assistant Researcher at the Affiliated Kunshan Hospital of Jiangsu University and a part-time postdoctoral researcher at the Suzhou Institute of Nano-tech and Nano-bionics. Zheng leads several high-impact projects, including studies on arjunolic acid and liposome-based therapies for NAFLD, supported by major funding bodies like the National Natural Science Foundation of China. His research is well-regarded, with numerous publications in leading journals such as Phytomedicine and J Functional Foods. Zheng has been honored with awards like Jiangsu Double Innovation Doctor and Gusu Health Talents Plan-“Class D special talents”. His work showcases significant contributions to the field, marked by a strong publication record and leadership in innovative research.

Profile
Education

Xian Zheng’s educational background reflects a strong foundation in pharmacology and pharmacy. He earned his Ph.D. in Chinese Pharmacy from the College of Traditional Chinese Medicine at China Pharmaceutical University, Nanjing, in December 2021, under the supervision of Professor Zhiqi Yin. Prior to this, he completed his Master of Science in Pharmacology at the School of Pharmacy, Xuzhou Medical University, in June 2018, guided by Professor Yi Liu. Zheng’s academic journey began with a Ph.D. in Pharmacy from the School of Pharmacy, Nanjing2 University of Chinese Medicine, which he completed in June 2015. This extensive education, encompassing both traditional Chinese medicine and modern pharmacology, has provided him with a robust understanding of drug development and therapeutic applications, particularly in the realm of natural products and their effects on nonalcoholic fatty liver disease.

Professional Experience

Xian Zheng currently serves as an Assistant Researcher at the Department of Pharmacy, Affiliated Kunshan Hospital of Jiangsu University, where he has been contributing to cutting-edge research since February 2022. Additionally, he is a part-time postdoctoral researcher at the Suzhou Institute of Nano-tech and Nano-bionics, a position he has held since October 2022. Zheng’s professional journey includes significant achievements in studying Chinese herbal drugs and natural products, particularly in the context of nonalcoholic fatty liver disease (NAFLD). He leads multiple high-profile research projects funded by prestigious organizations such as the National Natural Science Foundation of China and the Gusu Health Talent Research Project. His expertise in pharmacology and his leadership in these research initiatives highlight his dedication and impact in advancing therapeutic strategies for NAFLD and related conditions.

Research Interest

Xian Zheng’s research interests primarily focus on Chinese herbal drugs and natural products, with a particular emphasis on their therapeutic potential for nonalcoholic fatty liver disease (NAFLD). His work explores innovative treatment approaches, such as the dual NAMPT activation theory, and the development of liposome-based drug delivery systems to enhance the efficacy of herbal compounds. Zheng’s research aims to uncover the underlying mechanisms of these treatments, such as their effects on metabolic pathways and cellular functions. He is dedicated to advancing the understanding of how traditional herbal remedies can be optimized and integrated into modern therapeutic strategies for complex liver diseases. By combining traditional pharmacological insights with contemporary biomedical techniques, Zheng seeks to bridge the gap between ancient remedies and modern medicine, ultimately improving clinical outcomes for patients with NAFLD and contributing to the broader field of natural product research.

Research Skills

Xian Zheng demonstrates exceptional research skills, particularly in the domain of pharmacology and natural product research. His expertise encompasses a comprehensive understanding of Chinese herbal drugs and their therapeutic applications, with a specific focus on nonalcoholic fatty liver disease (NAFLD). Zheng excels in designing and leading innovative research projects, such as exploring dual NAMPT activation and developing liposome-based therapies for NAFLD. His ability to secure funding from prestigious organizations, including the National Natural Science Foundation of China, underscores his proficiency in research proposal development and project management. Zheng’s analytical skills are evident in his extensive publication record in reputable journals, where he contributes to advancing knowledge in his field. His role as a part-time postdoctoral researcher further reflects his commitment to scientific inquiry and collaboration. Overall, Zheng’s research skills are marked by a blend of innovative thinking, effective project leadership, and a strong publication track record.

Awards and Recognition

Xian Zheng has earned notable recognition in his field through a series of prestigious awards and honors. His achievements include being named a Jiangsu Double Innovation Doctor, which acknowledges his exceptional contributions to innovative research in Chinese pharmacy. Additionally, Zheng is distinguished as a “Class D special talents” under the Gusu Health Talents Plan, underscoring his impactful work in the realm of natural products and nonalcoholic fatty liver disease. He was also recognized as a Kunshan Youth Post Expert in 2022 and a Suzhou Youth Post Expert in 2023, highlighting his significant contributions to the scientific community and his leadership in advancing research. These accolades reflect Zheng’s dedication and impact in the field of pharmacology and his commitment to advancing therapeutic approaches through his innovative research efforts.

Conclusion

Dr. Tao Song is a strong candidate for the Best Researcher Award due to his significant contributions to the field of catalysis and green chemistry. His innovative research and high-impact publications demonstrate a clear potential for future leadership in the field. To further strengthen his candidacy, Dr. Song could focus on expanding the impact of his research through interdisciplinary collaborations and leadership roles. Given his achievements and potential, Dr. Song is well-suited for recognition as a leading researcher in his field.

Publications Top Notes

  1. Arjunolic Acid from Cyclocarya paliurus Selectively Inhibits Glucagon Secretion from α Cells and Ameliorates Diabetes via Ephrin-A1 and EphA4 Interaction
    • Authors: Fang, C.-Q., Teng, Y., Wang, Y.-T., Cao, X.-L., Jiang, C.-H.
    • Year: 2022
  2. Aloin A Prevents Ulcerative Colitis in Mice by Enhancing the Intestinal Barrier Function via Suppressing the Notch Signaling Pathway
    • Authors: Jiang, H., Shi, G.-F., Fang, Y.-X., Zhang, J., Yin, Z.-Q.
    • Year: 2022
    • Citations: 11
  3. Protective Effects of Cyclocarya paliurus on Hyperuricemia and Urate-Induced Inflammation
    • Authors: Zhu, L.-H., Xu, Y.-Y., Zhu, L.-P., Zhang, J., Yin, Z.-Q.
    • Year: 2022
    • Citations: 9
  4. Cyclocarya paliurus Triterpenoids Attenuate Glomerular Endothelial Injury in Diabetic Rats via ROCK Pathway
    • Authors: Yang, R., Xu, S., Zhang, X., Yin, Z., Pan, K.
    • Year: 2022
    • Citations: 8
  5. Chrysin Inhibits Hepatocellular Carcinoma Progression Through Suppressing Programmed Death Ligand 1 Expression
    • Authors: Rong, W., Wan, N., Zheng, X., Gao, Z.-J., Zhang, J.
    • Year: 2022
    • Citations: 17
  6. New Dammarane-Type Triterpenoid Saponins from Gynostemma pentaphyllum and Their Sirt1 Agonist Activity
    • Authors: Lou, Y.-Y., Zheng, X., Huang, Y.-P., Yin, Z.-Q., Pan, K.
    • Year: 2021
    • Citations: 12
  7. Arjunolic Acid from Cyclocarya paliurus Ameliorates Nonalcoholic Fatty Liver Disease in Mice via Activating Sirt1/AMPK, Triggering Autophagy and Improving Gut Barrier Function
    • Authors: Zheng, X., Zhang, X.-G., Liu, Y., Zhang, J., Yin, Z.-Q.
    • Year: 2021
    • Citations: 6
  8. Aloe Vera Mitigates Dextran Sulfate Sodium-Induced Rat Ulcerative Colitis by Potentiating Colon Mucus Barrier
    • Authors: Shi, G., Jiang, H., Feng, J., Jiang, C., Zhang, J.
    • Year: 2021
    • Citations: 30
  9. Four New Dammarane Triterpenoid Glycosides from the Leaves of Cyclocarya paliurus and Their SIRT1 Activation Activities
    • Authors: Zhu, L.-P., Yang, H.-M., Zheng, X., Zhang, J., Yin, Z.-Q.
    • Year: 2021
    • Citations: 7
  10. Gypenoside LVI Improves Hepatic LDL Uptake by Decreasing PCSK9 and Upregulating LDLR Expression
    • Authors: Wang, J., Wang, Y.-S., Huang, Y.-P., Yin, Z.-Q., Zhang, J.
    • Year: 2021
    • Citations: 21

 

Hend Hafez | Pharmaceutical Chemistry | Best Researcher Award

Published on by Shen Awards

Prof Dr. Hend Hafez | Pharmaceutical Chemistry | Best Researcher Award

Professor Dr at National Research Center, Egypt.

Prof. Dr. Hend Nagah Hafez Mohammed, an Egyptian national, is a distinguished figure in the field of organic chemistry. With a Ph.D. from Cairo University, she serves as a Professor of Applied Organic Chemistry at the National Research Centre in Cairo, Egypt. Throughout her career, she has made significant contributions to the synthesis and study of heterocyclic compounds with potential biological activity. Dr. Hafez has a strong research background, with expertise in microwave irradiation techniques, chromatography, X-ray diffraction analysis, and spectroscopic interpretation. Her dedication to scientific inquiry is evident through her participation in numerous international conferences and research projects. As an educator, she has mentored postgraduate and undergraduate students, sharing her knowledge and passion for chemistry. Dr. Hafez’s commitment to advancing the field of organic chemistry underscores her status as a respected academic and researcher in Egypt and beyond.

Professional Profiles:

Education

Prof. Dr. Hend Hafez holds a Ph.D. in Chemistry obtained in 2007 from the Faculty of Science at Cairo University, Egypt. Prior to this, she completed her M.Sc. in Chemistry in 2003, also at Cairo University, followed by a B.Sc. in Chemistry from El-Azhar University in 1999. Throughout her academic journey, Dr. Hafez has demonstrated a commitment to advancing her expertise in the field of organic chemistry, with a focus on synthesis and reactions of polynuclear heterocyclic compounds, among other areas. Her educational background serves as a solid foundation for her subsequent professional endeavors in research and academia.\

Professional Experience

Prof. Dr. Hend Hafez boasts a distinguished career in organic chemistry, spanning both academia and research. Currently serving as a Professor of Applied Organic Chemistry at the National Research Centre in Cairo, Egypt, she leads pioneering research initiatives in the Heterocyclic and Nucleosides Unit. With extensive experience dating back to 2007, she has held various roles, including Associate Professor and Researcher, contributing significantly to the field’s advancement. Prof. Hafez’s expertise encompasses diverse areas such as synthesis, reactions of polynuclear heterocyclic compounds, and the study of nitrogenous compounds’ biological activity. Her dedication to organic chemistry is reflected in her active participation in international conferences and her supervision of numerous postgraduate students. Through her impactful research and academic leadership, Prof. Hafez continues to shape the landscape of organic chemistry, making profound contributions to scientific knowledge and discovery.

Research Interest

Prof. Dr. Hend Hafez, an accomplished organic chemist, focuses on synthesizing novel compounds and exploring their biological activities. With expertise in microwave-assisted synthesis and chromatography separation, she aims to develop efficient and environmentally friendly methods for compound preparation. Her research also delves into the design of combinatorial libraries to identify potential drug candidates. Through X-ray diffraction analysis, she investigates the molecular structures of organic compounds, shedding light on their chemical properties. Prof. Hafez’s work spans various areas of organic chemistry, contributing to advancements in drug discovery and chemical synthesis.

Award and Honors

Prof. Dr. Hend Hafez has received several awards and honors for her outstanding contributions to the field of organic chemistry. Some of her notable accolades include recognition from prestigious international conferences such as the 22nd International Congress in Heterocyclic Chemistry and the 3rd European Conference on Chemistry for Life Sciences. Additionally, she has been acknowledged for her research endeavors with awards from the National Research Center in Cairo, Egypt, where she serves as a Professor of Applied Organic Chemistry. Her dedication to scientific inquiry and innovative research methodologies has earned her the respect and admiration of her peers in the academic community.

Research Skills

Prof. Dr. Hend Hafez possesses a diverse set of research skills that enable her to excel in the field of organic chemistry. Her expertise includes synthetic and medicinal chemistry, microwave irradiation techniques for green chemistry, design and evaluation of combinatorial libraries, chromatography separation methods, and X-ray diffraction analysis for structural determination. She is proficient in interpreting instrumental data from various spectroscopic techniques such as Mass Spectrometry, IR, UV, and NMR spectroscopy. Additionally, Dr. Hafez is skilled in conducting statistical analysis and using computational tools for data interpretation. Her research skills enable her to investigate complex chemical reactions, develop novel compounds with potential biological activity, and contribute significantly to the advancement of organic chemistry.

Publications

  1. Design, synthesis, antiproliferative, antituberculosis and in-silico analysis of New Schiff base derivatives of cyclohepta[b]thiophene
    • Authors: Hafez, H.N., Abbas, H.-A.S., El-Sayed, A.F.
    • Year: 2024
  2. Exploring the Antiproliferative Potency of Pyrido[2,3-d]Pyrimidine Derivatives: Studies on Design, Synthesis, Anticancer Evaluation, SAR, Docking, and DFT Calculations
    • Authors: Abd-Alsalam, E., Hafez, H.N., Assay, M.G., … El-Farargy, A.F., Abbass, E.M.
    • Year: 2024
  3. Synthesis and Reactions of Thieno[2,3-c]quinolines from Arylaldehyde and Arylamine Derivatives: A Review (Part VIII)
    • Authors: Abu-Hashem, A.A., El-Gazzar, A.-R.B.A., Hafez, H.N., Abdelgawad, A.A.M., Gouda, M.A.
    • Year: 2024
    • Citations: 2
  4. Synthesis, design, and antimicrobial activity of pyrido[2,3-d][1,2,4]triazolo[4,3-a]pyrimidinones based on quinoline derivatives
    • Authors: Abu-Hashem, A.A., Yousif, M.N.M., El-Gazzar, A.-R.B.A., Hafez, H.N.
    • Year: 2023
    • Citations: 2
  5. Synthesis and Antimicrobial Activity of New Triazines, Tetrazines, Thiazinoquinoxalines, Thienotriazepine-imidazo[4, 5-b]quinolines from Isatin Derivatives
    • Authors: Abu-Hashem, A.A., El-Gazzar, A.B.A., Hussein, H.A.R., Hafez, H.N.
    • Year: 2023
    • Citations: 3
  6. Synthesis and Biological Evaluation of Novel Quinazoline, Chromene and Chromeno[2,3-d]pyrimidine Derivatives
    • Authors: Yousif, M.N.M., El-Gazzar, A.-R.B.A., Hafez, H.N., Yousif, N.M.
    • Year: 2022
    • Citations: 0
  7. Recent Advances in the Chemistry and Biological Activity of Sulfonamide Derivatives
    • Authors: Yousif, M.N.M., El-Gazzar, A.-R.B.A., Hafez, H.N., … Elrashedy, A., Yousif, N.M.
    • Year: 2022
    • Citations: 6
  8. Synthesis and Antimicrobial, Anticancer and Anti-Oxidant Activities of Novel 2,3-Dihydropyrido[2,3-d]pyrimidine-4-one and Pyrrolo[2,1-b][1,3]benzothiazole Derivatives via Microwave-Assisted Synthesis
    • Authors: Al-Mutairi, A.A., Hafez, H.N., El-Gazzar, A.-R.B.A., Mohamed, M.Y.A.
    • Year: 2022
    • Citations: 5
  9. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents
    • Authors: Hafez, H.N., El-Gazzar, A.-R.B.A.
    • Year: 2020
    • Citations: 6
  10. Design, synthesis, and biological evaluation of n-phenylpyrazole derivatives featuring nitrogen-containing side chains as potent antitumor agents
    • Authors: Hafez, H.N., El-Gazzar, A.-R.B.A., Ali, A.S., Alakhras, A.I.A.
    • Year: 2019
    • Citations: 3